Indaptus Therapeutics, Inc.
INDP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001857044
No open-market purchases or sales by Indaptus Therapeutics, Inc. insiders were filed in the last 90 days; 9 institutions reported holding it in 13F filings for Q2 2026, worth $1.15M in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Indaptus Therapeutics, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 17
- +3 vs. Q4 2021
- Shares held
- 1.71M
- −123.8K (−6.7%) vs. Q4 2021
- Total value
- $6.81M
- −$3.65M (−34.9%) vs. Q4 2021
- New holders
- 6
- 2 more added
- Sold out
- 3
- 4 more reduced
1 institution that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting INDP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 9 | $1.15M |
| Q1 2026 | 6 | $128.5K |
| Q4 2025 | 4 | $93.7K |
| Q3 2025 | 5 | $57.9K |
| Q2 2025 | 5 | $3.23K |
| Q1 2025 | 19 | $377.8K |
| Q4 2024 | 20 | $539.6K |
| Q3 2024 | 18 | $750.2K |
| Q2 2024 | 21 | $1.26M |
| Q1 2024 | 17 | $1.31M |
| Q4 2023 | 19 | $1.06M |
| Q3 2023 | 16 | $1.57M |
| Q2 2023 | 15 | $1.11M |
| Q1 2023 | 15 | $1.08M |
| Q4 2022 | 18 | $838.5K |
| Q3 2022 | 18 | $1.22M |
| Q2 2022 | 17 | $1.31M |
| Q1 2022 | 17 | $6.81M |
| Q4 2021 | 15 | $10.5M |
| Q3 2021 | 15 | $4.24M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Indaptus Therapeutics, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Stratos Wealth Partners, LTD. | 1,188,356 | $4.75M | 0.11% | −200,000−14.4% | Reduced |
| Vanguard Group Inc | 242,235 | $969.0K | 0.00% | +38,216+18.7% | Added |
| Geode Capital Management, LLC | 113,046 | $452.0K | 0.00% | +27,132+31.6% | Added |
| Investment House LLC | 95,629 | $383.0K | 0.03% | 00.0% | Unchanged |
| State Street Corp | 19,473 | $78.0K | 0.00% | +19,473 | New |
| United Capital Financial Advisers, LLC | 15,000 | $60.0K | 0.00% | 00.0% | Unchanged |
| Vivaldi Capital Management, LLC | 24,000 | $60.0K | 0.02% | +24,000 | New |
| Northern Trust Corp | 10,296 | $41.0K | 0.00% | +10,296 | New |
| UBS Group AG | 3,294 | $13.0K | 0.00% | −1,638−33.2% | Reduced |
| Morgan Stanley | 547 | $2.00K | 0.00% | 00.0% | Unchanged |
| National Bank of Canada | 500 | $2.00K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 98 | $0 | 0.00% | −300−75.4% | Reduced |
| Group One Trading, L.P. | 6 | $0 | 0.00% | −7−53.8% | Reduced |
| Steward Partners Investment Advisory, LLC | 28 | $0 | 0.00% | 00.0% | Unchanged |
| Cambridge Trust Co | 47 | $0 | 0.00% | +47 | New |
| Captrust Financial Advisors | 13 | $0 | 0.00% | +13 | New |
| Creative Planning | 63 | $0 | 0.00% | +63 | New |
| Millennium Management LLC | 0 | $0 | 0.00% | −38,040−100.0% | Sold out |
| Harel Insurance Investments & Financial Services Ltd. | 0 | $0 | 0.00% | −2,958−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −82−100.0% | Sold out |
| Reilly Financial Advisors, LLC | – | – | – | – | Not filed |